The need for future coronary access in older medicare beneficiaries following transcatheter aortic-valve replacement

被引:0
作者
Brown, Christopher [1 ]
Ryan, Michael [2 ]
Kelley, Marcella [3 ]
Thompson, Christin [3 ]
Gunnarsson, Candace [4 ]
Hermiller Jr, James [5 ]
机构
[1] Swedish Heart & Vasc Inst, 550 17th Ave Suite 680, Seattle, WA 98122 USA
[2] MPR Consulting, Cincinnati, OH USA
[3] Edwards Lifesciences, Irvine, CA USA
[4] Gunnarsson Consulting, Jupiter, FL USA
[5] Ascension St Vincents Heart Ctr Indiana, Indianapolis, IN USA
关键词
Coronary access; TAVR; Medicare beneficiaries; ARTERY-DISEASE; INTERVENTION; STENOSIS; RISK; OUTCOMES; TAVR; BIOPROSTHESIS; IMPLANTATION; FEASIBILITY; ANGIOGRAPHY;
D O I
10.1007/s12928-025-01171-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundWhile approximately 17% of patients less than 80 years old require coronary access in the 7 years following their TAVR, the need for coronary access among older TAVR patients is unknown. Methods: We examined the percentage of Medicare beneficiaries aged 80-90 years that require coronary access [percutaneous coronary intervention (PCI) or angiogram] in the 8 years following their TAVR using data from the Medicare 5% Standard Analytic File (2011-2021). The need for coronary access in older patients was estimated for all TAVRs, TAVR patients with and without a history of PCI, and TAVR patients with and without coronary artery disease (CAD) using time-to-event models adjusted for age, sex, race, region, ECI score, concomitant CABG, CAD, PCI, and current or recent smoker status. Multivariate log-gamma regressions were used to estimate the total cost of hospitalizations requiring coronary access post-TAVR. Results: A total of 6845 patients met inclusion criteria. The incidence rates for undergoing PCI or angiogram at 1, 3, 5, and 8 years were 1.9%, 4.0%, 5.5%, and 6.3%, respectively. TAVR patients with PCI demonstrated higher rates of coronary intervention compared to those without PCI (10.2% vs. 6.2% at 8 years, respectively). Similarly, TAVR patients with a prior CAD diagnosis exhibited increased rates of coronary intervention compared to those without a prior CAD diagnosis (7.4% vs. 2.1% at 8 years, respectively). The mean adjusted cost of hospitalizations requiring coronary access was $30,170 [95% Confidence Interval: $27,865-$32,665]. Conclusions: Approximately 6.8% of older TAVR patients require coronary access in the 8 years following their index procedure. The presence of a prior PCI or CAD diagnosis is associated with an increased requirement for subsequent coronary access.
引用
收藏
页数:9
相关论文
共 39 条
[1]   Coronary Access After TAVR With a Self-Expanding Bioprosthesis [J].
Abdelghani, Mohammad ;
Landt, Martin ;
Traboulsi, Hussein ;
Becker, Bjorn ;
Richardt, Gert .
JACC-CARDIOVASCULAR INTERVENTIONS, 2020, 13 (06) :709-722
[2]   Incidence, feasibility and outcome of percutaneous coronary intervention after transcatheter aortic valve implantation with a self-expanding prosthesis. Results from a single center experience [J].
Allali, Abdelhakim ;
El-Mawardy, Mohamed ;
Schwarz, Bettina ;
Sato, Takao ;
Geist, Volker ;
Toelg, Ralph ;
Richardt, Gert ;
Abdel-Wahab, Mohamed .
CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2016, 17 (06) :391-398
[3]   Coronary Artery Disease and Outcomes of Aortic Valve Replacement for Severe Aortic Stenosis [J].
Beach, Jocelyn M. ;
Mihaljevic, Tomislav ;
Svensson, Lars G. ;
Rajeswaran, Jeevanantham ;
Marwick, Thomas ;
Griffin, Brian ;
Johnston, Douglas R. ;
Sabik, Joseph F., III ;
Blackstone, Eugene H. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (08) :837-848
[4]   Challenges of coronary angiography and intervention in patients previously treated by TAVI [J].
Blumenstein, Johannes ;
Kim, Won-Keun ;
Liebetrau, Christoph ;
Gaede, Luise ;
Kempfert, Joerg ;
Walther, Thomas ;
Hamm, Christian ;
Moellmann, Helge .
CLINICAL RESEARCH IN CARDIOLOGY, 2015, 104 (08) :632-639
[5]   Coronary Procedures After TAVI With the Self-Expanding Aortic Bioprosthesis Medtronic CoreValve™, Not an Easy Matter [J].
Boukantar, Madjid ;
Gallet, Romain ;
Mouillet, Gauthier ;
Belarbi, Abdelkaoui ;
Rubimbura, Vladimir ;
Ternacle, Julien ;
Dubois-Rande, Jean-Luc ;
Teiger, Emmanuel .
JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2017, 30 (01) :56-62
[6]   Outcomes in Patients With Transcatheter Aortic Valve Replacement and Left Main Stenting The TAVR- LM Registry [J].
Chakravarty, Tarun ;
Sharma, Rahul ;
Abramowitz, Yigal ;
Kapadia, Samir ;
Latib, Azeem ;
Jilaihawi, Hasan ;
Poddar, Kanhaiya Lal ;
Giustino, Gennaro ;
Ribeiro, Henrique B. ;
Tchetche, Didier ;
Monteil, Benoit ;
Testa, Luca ;
Tarantini, Giuseppe ;
Facchin, Michela ;
Lefevre, Thierry ;
Lindman, Brian R. ;
Hariri, Babak ;
Patel, Jigar ;
Takahashi, Nobuyuki ;
Matar, George ;
Mirocha, James ;
Cheng, Wen ;
Tuzcu, Murat E. ;
Sievert, Horst ;
Rodes-Cabau, Josep ;
Colombo, Antonio ;
Finkelstein, Ariel ;
Fajadet, Jean ;
Makkar, Raj R. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (08) :951-960
[7]  
Coylewright M, 2022, Treatment of aortic stenosis by age in the US: Evidence of institutional ageism
[8]   Clinical Conundrum of Coronary Artery Disease and Aortic Valve Stenosis [J].
El Sabbagh, Abdallah ;
Nishimura, Rick A. .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (02)
[9]   Comorbidity measures for use with administrative data [J].
Elixhauser, A ;
Steiner, C ;
Harris, DR ;
Coffey, RN .
MEDICAL CARE, 1998, 36 (01) :8-27
[10]  
Elmariah S, 2022, Treatment of aortic stenosis by age in the US: evidence of institutional ageism